After-Hours Stock Movers 08/31: (PLAN) (PVH) (AMBA) Higher; (CRWD) (ASND) Lower (more...)
After-Hours Stock Movers:
Anaplan, Inc. (NYSE: PLAN) 14.5% HIGHER; reported Q2 EPS of ($0.09), $0.05 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $144.3 million versus the consensus estimate of $133.99 million. Anaplan, Inc. sees FY2022 revenue of $571.5-573.5 million, versus the consensus of $558 million.
PVH Corp. (NYSE: PVH) 8% HIGHER; reported Q2 EPS of $2.72, $1.52 better than the analyst estimate of $1.20. Revenue for the quarter came in at $2.31 billion versus the consensus estimate of $2.14 billion. PVH Corp. sees FY2021 EPS of $8.50, versus the consensus of $6.75. Revenue in 2021 is projected to increase 26% to 28% (increase 24% to 26% on a constant currency basis) as compared to 2020.
Ambarella (NASDAQ: AMBA) 6.3% HIGHER; reported Q2 EPS of $0.35, $0.10 better than the analyst estimate of $0.25. Revenue for the quarter came in at $79.3 million versus the consensus estimate of $75.68 million. Ambarella sees third-quarter revenue of $88.0 million and $92.0 million, versus the consensus of $78.7 million.
Caleres (NYSE: CAL) 5% HIGHER; reported Q2 EPS of $1.19, $0.66 better than the analyst estimate of $0.53. Revenue for the quarter came in at $675.5 million versus the consensus estimate of $640.4 million.
CrowdStrike Holdings Inc. (NASDAQ: CRWD) 4.2% LOWER; reported Q2 EPS of $0.11, $0.02 better than the analyst estimate of $0.09. Revenue for the quarter came in at $337.7 million versus the consensus estimate of $323.13 million. CrowdStrike Holdings Inc. sees Q3 2022 EPS of $0.08-$0.10, versus the consensus of $0.09. CrowdStrike Holdings Inc. sees Q3 2022 revenue of $358-365.3 million, versus the consensus of $350.92 million.
Calyxt (NASDAQ: CLXT) 4% HIGHER; President/CEO, Michael Carr, bought 10,000 shares on 08/03 at $3.9776.
Ascendis Pharma A/S (Nasdaq: ASND) 3.6% LOWER; announced that it has commenced an underwritten public offering of $400,000,000 of American Depositary Shares (“ADSs”), each of which represents one ordinary share of Ascendis.
Playtika Holding Corp. (NASDAQ: PLTK) 1.5% HIGHER; announced today its acquisition of Reworks Oy, maker of hit Design Entertainment app, Redecor. In 18 months since its launch, Redecor has grown to become the #2 Design Entertainment app based on in-app purchase revenue. Playtika, a leader in mobile gaming, live-ops and technology, will leverage its expertise to further grow Redecor into a leading destination for Design enthusiasts for years to come.
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) 1.4% HIGHER; Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and MedinCell (Euronext: MEDCL) announced today that the New Drug Application (NDA) for TV-46000/mdc-IRM (risperidone extended-release injectable suspension for subcutaneous use) for the treatment of schizophrenia has been accepted by the U.S. Food and Drug Administration (FDA).